stars 1 stars 2 stars 3

CBT Advisors is a consultancy founded in 2003 working with private biotechnology, life sciences and medical device companies on storytelling and strategy. We are based in Cambridge, MA. Much of the firm’s work focuses on drafting business sections for NASDAQ IPOs. As of October, 2020, fifty-nine clients have gone public, raising $5.9 billion. Recent IPO clients have included Zentalis, Repare, Black Diamond, Pliant Therapeutics, iTeos, Legend Biotech and Allovir. Earlier clients included CRISPR Therapeutics, Karuna Therapeutics, Alector, Translate Bio, ArgenX, Personalis, Inspire Medical, Vapotherm and others.

CBT Advisors Questions

The CBT Advisors annual revenue was $192000 in 2026.

Steven Dickman is the Founder and CEO of CBT Advisors.

2 people are employed at CBT Advisors.

CBT Advisors is based in Cambridge, Massachusetts.

The NAICS codes for CBT Advisors are [541, 54171, 541713, 54, 5417].

The SIC codes for CBT Advisors are [87, 873].

Top CBT Advisors Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users